On January 29, the European Parliament held a hearing on "over-reliance on imports of pharmaceutical active ingredients." The Public Health Committee meeting discussed the European Union's dependence on the supply of active ingredients from Asia, which has led to a partial loss of the ability to produce them on its own, posing a potential threat to public health in member states. The public hearing was a prelude to a discussion on ways to promote the production of active substances and finished medicines in Europe.
Chairman of the Public Health Committee (SANT) Adam Jarubas noted that it is necessary to create comprehensive mechanisms for increasing the production of pharmaceutical substances and medicines. These are to be included in the Critical Medicines Act, the assumptions of which are expected to appear in February this year.
Krz...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.
